References
- Mercier Ythier J. Cultured blood versus donated blood: long-run perspectives of the economy of blood. Bio-Med Mater Eng. 2015;25(s1):199–209.
- Blood Needs & Blood Supply. 2019. https://www.redcrossblood.org/donate-blood/how-to-donate/ how-blood-donations-help/blood needs-blood-supply.html
- Eastridge BJ, Hardin M, Cantrell J, et al. Died of wounds on the battlefield: causation and implications for improving combat casualty care. J Trauma. 2011;71(1):S4–S8.
- Holcomb JB, McMullin NR, Pearse L, et al. Causes of death in US special operations forces in the global war on terrorism: 2001–2004. Ann Surg. 2007;245(6):986–991.
- Eastridge BJ, Mabry RL, Seguin P, et al. Death on the battlefield (2001–2011): implications for the future of combat casualty care. J Trauma Acute Care Surg. 2012;73(6):S431–S437.
- Natanson C, Kern SJ, Lurie P, et al. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA. 2008;299(19):2304–2312.
- Silverman TA, Weiskopf RB, Planning Committee and the Speakers. Hemoglobin-based oxygen carriers: current status and future directions. J Am Soc Anesthesiol. 2009;111(5):946–963.
- García-Ruiz JM, Galán-Arriola C, Fernández-Jiménez R, et al. Bloodless reperfusion with the oxygen carrier HBOC-201 in acute myocardial infarction: a novel platform for cardioprotective probes delivery. Basic Res Cardiol. 2017;112(2):17.
- Lo KK, Bey EA, Patra B, et al. Hemoglobin-based oxygen carrier mitigates transfusion-mediated pancreas cancer progression. Ann Surg Oncol. 2013;20(6):2073–2077.
- Lee NP, Chan KT, Choi MY, et al. Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts. Cancer Chemother Pharmacol. 2015;76(6):1199–1207.
- Li CX, Wong BL, Ling CC, et al. A novel oxygen carrier “YQ23” suppresses the liver tumor metastasis by decreasing circulating endothelial progenitor cells and regulatory T cells. BMC Cancer. 2014;14(1):1–8.
- Munoz CJ, Pires IS, Baek JH, et al. Apohemoglobin-haptoglobin complex attenuates the pathobiology of circulating acellular hemoglobin and heme. Am J Physiol Heart Circ Physiol. 2020;318(5):H1296–H1307.
- Kewei Y, Guoying S, Yanpeng Z, et al. A preparation method of polymerized hemoglobin with low polymer content: CN111217904A[P]. 2020-06-02.
- Li F, Zhang H, Wang J, et al. Purification and viral inactivation of hemoglobin from human placenta blood. Artif Cells Blood Substit Immobil Biotechnol. 2009;37(2):57–60.
- Meledeo MA, Peltier GC, McIntosh CS, et al. Freeze-dried plasma mitigates the dilution effects of a hemoglobin-based oxygen carrier (HBOC-201) in a model of resuscitation for hemorrhage and hemodilution. J Trauma Acute Care Surg. 2019;87(1):S83–S90.
- Gupta AS. Hemoglobin-based oxygen carriers: Current state-of-the-art and novel molecules. Shock (Augusta, GA). 2019;52(1):70.
- Benitez Cardenas AS, Samuel PP, Olson JS. Current challenges in the development of acellular hemoglobin oxygen carriers by protein engineering. Shock. 2019;52(1):28–40.
- D’Agnillo F, Alayash AI. Site-specific modifications and toxicity of blood substitutes. The case of diaspirin cross-linked hemoglobin. Adv Drug Deliv Rev. 2000;40(3):199–212.
- Laberge M, Kövesi I, Yonetani T, et al. R-state hemoglobin bound to heterotropic effectors: models of the DPG, IHP and RSR13 binding sites. FEBS Lett. 2005;579(3):627–632.
- Alyash A. Redox and radical reactions of hemoglobin solutions: toxicities and protective strategies. Blood substitutes. London: Academic Press; 2006. p. 197–205.
- Eike JH, Palmer AF. Effect of Cl- and H + on the oxygen binding properties of glutaraldehyde-polymerized bovine hemoglobin-based blood substitutes. Biotechnol Prog. 2004;20(5):1543–1549.
- Cai J, Meng W, Yuan Z, et al. Effect of different reaction conditions on properties of DBBF-modified porcine hemoglobin products. J Zhejiang Univ (Eng Sci). 2009;43(12):2323–2326.
- Alayash AI, Summers AG, Wood F, et al. Effects of glutaraldehyde polymerization on oxygen transport and redox properties of bovine hemoglobin. Arch Biochem Biophys. 2001;391(2):225–234.
- Zhou W, Zhang H, Chen G, et al. Guiding principles for designing research on HBOCs[M]//NANOBIOTHERAPEUTIC BASED BLOOD SUBSTITUTES. Series Editor:Thomas Ming Swi Chang.World Scientific Publishing Co. Pte. Ltd. 5 Toh Tuck Link, Singapore. 2022. p. 39–62.
- Li Y, Yan D, Hao S, et al. Polymerized human placenta hemoglobin improves resuscitative efficacy of hydroxyethyl starch in a rat model of hemorrhagic shock. Artif Cells Nanomed Biotechnol. 2015;43(3):174–179.
- Chen JY, Scerbo M, Kramer G. A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. Clinics. 2009;64(8):803–813.
- Alayash AI. Blood substitutes: why haven’t we been more successful. Trends Biotechnol. 2014;32(4):177–185.
- Yu B, Liu Z, Chang TMS. Polyhemoglobin with different percentage of tetrameric hemoglobin and effects on vasoactivity and electrocardiogram. Artif Cells Blood Substit Immobil Biotechnol. 2006;34(2):159–173.
- Kim HW, Greenburg AG. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status. Artif Organs. 2004;28(9):813–828.
- Antończyk A, Ochota M, Niżański W. Umbilical cord blood gas parameters and apgar scoring in assessment of new-born dogs delivered by cesarean section. Animals. 2021;11(3):685–697.
- Nicolescu LC, Nicolescu CM, Mihu AG, et al. The effect of red blood cell transfusion on peripheral tissue oxygen delivery and consumption in septic patients. Transfus Clin Biol. 2021;28(1):5–10.
- Gonzales Carazas MM, Gavidia CM, Davila Fernandez R, et al. Biological evaluation of a mechanical ventilator that operates by controlling an automated manual resuscitator. A descriptive study in swine. PLoS One. 2022;17(3):e0264774(1–18).